CELG

Celgene Corporation News Headlines

$91.36
*  
0.05
0.05%
Get CELG Alerts
*Delayed - data as of Aug. 19, 2014  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CELG Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog
8/19/2014 1:20:00 PM - Zacks.com

Noteworthy ETF Outflows: IYH, AMGN, BIIB, CELG
8/19/2014 11:03:17 AM - BNK Invest

Celgene's Phase II Trial Of REVLIMID With R-CHOP Shows Positive Results
8/19/2014 7:53:00 AM - RTT News

3 Reasons Celgene Corporation's Stock Could Rise
8/18/2014 12:58:18 PM - Motley Fool

Taking Profits From Netflix And Putting Them To Work In Celgene
8/18/2014 12:41:00 PM - Seeking Alpha

Jim Cramer Answers Twitter (TWTR) Questions on Walmart (WMT), Yelp (YELP), Kinder Morgan (KMI) and More
8/18/2014 12:40:00 PM - TheStreet

Epizyme Holds A Key To A Potential Blockbuster Drug For Hematological Cancers
8/18/2014 11:24:00 AM - Seeking Alpha

#PreMarket Primer: Thursday, August 14: Investors Are Unfazed By Weak Retail Sales
8/14/2014 7:20:53 AM - Benzinga

ETF Outlook: SPDR S&P Biotech ETF (XBI)
8/13/2014 8:22:34 AM - Marc Chaikin

Cramer's Mad Money - The Most Bountiful M&A Year I Have Seen (8/11/14)
8/12/2014 5:42:00 AM - Seeking Alpha

Cramer's Mad Money - 12 Things To Watch In The Week Ahead (8/8/14)
8/11/2014 6:48:00 AM - Seeking Alpha

12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds
8/10/2014 10:54:00 AM - Seeking Alpha

Mylan Misses Q2 Earnings and Sales Estimates, Adjusts View - Analyst Blog
8/7/2014 11:15:00 AM - Zacks.com

Celgene: Abraxane Gets Health Canada Approval For Metastatic Pancreatic Cancer
8/6/2014 8:55:00 AM - RTT News

ClearBridge Value: Making It A Top Mutual Fund Again
8/5/2014 6:30:00 PM - Investor's Business Daily

Amgen's Multiple Myeloma Drug Kyprolis Succeeds - Analyst Blog
8/5/2014 6:21:00 PM - Zacks.com

Who Will Be Swimming Naked When The Tide Goes Out? (Part III)
8/5/2014 4:52:00 PM - Seeking Alpha

Aspire Data A Big Plus For Amgen And Celgene
8/5/2014 4:02:00 PM - Seeking Alpha

Regeneron Misses on Earnings in Q2, Eylea Drives Sales Beat - Analyst Blog
8/5/2014 3:02:00 PM - Zacks.com

Update: Lemelson Capital Further Increases Short Stake In Ligand Pharmaceuticals As EPS Plunges 76% In Q2 2014
8/4/2014 3:10:00 PM - Seeking Alpha

Acorda Beats on Q2 Earnings & Revenues, Maintains View - Analyst Blog
8/4/2014 9:20:00 AM - Zacks.com

Pharmacyclics Incurs Q2 Loss, Revenues Up on Imbruvica Sales - Analyst Blog
8/1/2014 5:10:00 PM - Zacks.com

Endo International Beats on Q2 Earnings & Sales, Guidance Up - Analyst Blog
8/1/2014 3:36:00 PM - Zacks.com

Incyte Posts Wider-than-Expected Q2 Loss, Raises Sales View - Analyst Blog
8/1/2014 11:17:00 AM - Zacks.com

BioMarin Q2 Loss Narrower than Expected, Revenue Guidance Up - Analyst Blog
7/31/2014 5:00:00 PM - Zacks.com